01-08-2002 | Short Communication
Serum concentrations of the interferon-γ-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease
Published in: Diabetologia | Issue 8/2002
Login to get access